Sfoglia per AUTORE
PATRIARCA A
Collezione AOU Novara

  

Items : 41

Prescription patterns of venetoclax in acute myeloid leukemia. in Hematological oncology / Hematol Oncol. 2024 Jul;42(4):e3298. doi: 10.1002/hon.3298.

2024
AOU Novara

Ucciero A; Traversa G; Pisterna A; Cardinali V; Sciabolacci S; Poloni A; Capelli D; Gaidano G; Patriarca A; Lunghi M;

Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia. in Cancer / Cancer. 2024 Jan;130(2):287-299. doi: 10.1002/cncr.35021. Epub 2023 Oct 6.

2024
AOU Città della Salute di Torino
AOU Novara

Cella D; Cortes J; Vignetti M; Rosti G; Dinner S; Altman JK; Fava C; Abruzzese E; Giai V; Iurlo A; Luciano L; Tiribelli M; Breccia M; Miggiano MC; Capodanno I; Patriarca A; Bonifacio M; Caocci G; Kota V; Castagnetti F; Efficace F; Yanez B; Cottone F;

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes. in Annals of hematology / Ann Hematol. 2024 Feb;103(2):437-442. doi: 10.1007/s00277-023-05577-9. Epub 2023 Dec 7.

2024
AOU Novara
AOU Città della Salute di Torino

Bellini M; Finazzi MC; Rambaldi A; Tognoni G; Cattaneo D; Vianelli N; Scaffidi L; Bucelli C; Lunghi F; Ramundo F; Betti S; Gesullo F; Guglielmelli P; Calabresi L; Loscocco GG; Cacciola E; Cascavilla N; Mora B; Rumi E; Patriarca A; Siragusa S; Rapezzi D; Musolino C; Caramella M; Pane F; Ricco A; Carli G; Palandri F; Benevolo G; et alii...

Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies. in Cancers / Cancers (Basel). 2023 Sep 18;15(18):4618. doi: 10.3390/cancers15184618.

2023
AOU Novara

Patriarca A; Gaidano G; Barone-Adesi F; Pisterna A; Scotti L; Ucciero A; Pagnoni F; Lunghi M;

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Oct 1;41(28):4486-4496. doi: 10.1200/JCO.22.02699. Epub 2023 Jun 9.

2023
ASL Biella
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Latagliata R; Zini G; Rizzo L; Bova I; D'Errigo MG; Cufari P; Arcadi MT; Delfino IM; Liberati AM; Candoni A; Rivellini F; Buccisano F; Stamatoullas-Bastard A; Ricco A; Palumbo GA; Impera S; Di Renzo N; Fenaux P; Germing U; Molteni A; Bocchia M; Beltrami G; Russo E; Castelli A; Fattizzo B; Guarini A; Tripepi G; Iannì G; Reda G; et alii...

MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Nov 10;41(32):4993-5004. doi: 10.1200/JCO.22.01972. Epub 2023 Mar 7.

2023
AOU Novara

Kiladjian JJ; Cui J; Salama ME; Colak G; Wondergem MJ; Hoffman R; Somervaille TCP; Granacher N; Scandura JM; Talpaz M; Hobbs G; Mead AJ; Rampal RK; Passamonti F; Devos T; Palandri F; Patriarca A; Kremyanskaya M; Mascarenhas J; Vannucchi AM; Verstovsek S; Curto-García N; Harrison C; Gupta V;

SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria. in Haematologica / Haematologica. 2023 Aug 17. doi: 10.3324/haematol.2023.283863.

2023
AO Ordine Mauriziano
AOU Novara

Lanza F; Gavriilaki E; Drexler B; Cignetti A; Beier F; Szmigielska-Kaplon A; Loschi M; Patriarca A; Drozd-Sokolowska J; Xicoy B; Giammarco S; Desnica L; Ingram W; Zaidi U; Fattizzo B; Tjon JM; Kulagin A; Verheggen I; Eikema DJ; Griffin M; Orvain C; Risitano AM; De la Camara R; De Latour RP;

Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Apr 1;41(10):1888-1897. doi: 10.1200/JCO.22.00437. Epub 2022 Dec 1.

2023
AOU Novara

Mossuto S; Puttrich M; Götze K; Stamatoullas A; Patriarca A; Navarro R; Onida F; Metzgeroth G; Jaekel N; Park S; Pelizzari AM; Germing U; Torregrosa Diaz JM; Wattel E; Zini G; Goasguen J; Nimubona S; Sapena R; Lübbert M; Droin N; Morabito M; Giagounidis A; Chaffaut C; Ades L; Thepot S; Santini V; Itzykson R; Solary E; Gloaguen S; et alii...

Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis. in Future oncology (London, England) / Future Oncol. 2022 Sep;18(27):2987-2997. doi: 10.2217/fon-2022-0484. Epub 2022 Aug 11.

2022
AOU Novara

Harrison CN; Gupta VK; Gerds AT; Rampal R; Verstovsek S; Talpaz M; Kiladjian JJ; Mesa R; Kuykendall AT; Vannucchi AM; Palandri F; Grosicki S; Devos T; Jourdan E; Wondergem MJ; Al-Ali HK; Buxhofer-Ausch V; Alvarez-Larrán A; Patriarca A; Kremyanskaya M; Mead AJ; Akhani S; Sheikine Y; Colak G; Mascarenhas J;

Breakthrough infections in MPN-COVID vaccinated patients. in Blood cancer journal / Blood Cancer J. 2022 Nov 15;12(11):154. doi: 10.1038/s41408-022-00749-8.

2022
AOU Novara
AOU Città della Salute di Torino
AO Alessandria

Vannucchi AM; Rambaldi A; Benajiba L; Carbonell S; Kulikowska de Na??cz A; Cattaneo D; Bucelli C; Betti S; Curto-Garcia N; Cavalca F; Borsani O; Guenova M; Navas Elorza B; Angona A; Cichocka E; Lopez Abadia E; Carli G; Xicoy Cirici B; Kusec R; Sagues Serrano M; Garcia-Gutierrez V; Sanchez AM; Hernandez-Boluda JC; Griesshammer M; Kiladjian JJ; Bolaños Calderón E; Heidel FH; Magro Mazo E; Quiroz Cervantes K; et alii...

High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module. in Hepatology communications / Hepatol Commun. 2022 Nov;6(11):3006-3014. doi: 10.1002/hep4.2070. Epub 2022 Sep 9.

2022
AOU Novara

Rigamonti C; Cittone MG; Manfredi GF; Sorge A; Moia R; Patriarca A; Donato MF; Gaidano G; Pirisi M; Fraquelli M;

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries. in Journal for immunotherapy of cancer / J Immunother Cancer. 2022 Nov;10(11):e005732. doi: 10.1136/jitc-2022-005732.

2022
AOU Novara

Cortellini A; Dettorre GM; Dafni U; Aguilar-Company J; Castelo-Branco L; Lambertini M; Gennatas S; Angelis V; Sita-Lumsden A; Rogado J; Pedrazzoli P; Viñal D; Prat A; Rossi M; Berardi R; Alonso-Gordoa T; Grisanti S; Dimopoulou G; Queirolo P; Pradervand S; Bertuzzi A; Bower M; Arnold D; Salazar R; Tucci M; Harrington KJ; Mazzoni F; Mukherjee U; Tsourti Z; et alii...

Second versus first wave of COVID-19 in patients with MPN. in Leukemia / Leukemia. 2022 Mar;36(3):897-900. doi: 10.1038/s41375-022-01507-2. Epub 2022 Jan 21.

2022
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Quiroz Cervantes K; Benevolo G; Vannucchi AM; Carobbio A; Ghirardi A; Carioli G; Sobas MA; Elli EM; Rumi E; De Stefano V; Curto-Garcia N; Benajiba L; Bellini M; Rambaldi A; Cavalca F; Borsani O; Betti S; Masternak Kulikowska de Na??cz A; Bucelli C; Cichocka E; Cattaneo D; Koschmieder S; Lopez Abadia E; Angona A; Xicoy Cirici B; Navas Elorza B; Kusec R; Sagues Serrano M; Osorio S; et alii...

COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry. in Journal of the National Cancer Institute / J Natl Cancer Inst. 2022 Jul 11;114(7):979-987. doi: 10.1093/jnci/djac057.

2022
AO Alessandria
AOU Novara

Ruiz-Camps I; Pinato DJ; Bower M; Diamantis N; Sinclair A; Colomba E; Tondini C; Maconi A; Betti M; Zambelli A; Guida A; Giusti R; Zoratto F; Queirolo P; Parisi A; Lambertini M; Tagliamento M; Mazzoni F; Tucci M; Berardi R; Generali D; Grisanti S; Provenzano S; Vincenzi B; Libertini M; Sanchez de Torre A; Rimassa L; Rossi S; Harbeck N; et alii...

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study. in The Lancet. Oncology / Lancet Oncol. 2022 Jul;23(7):865-875. doi: 10.1016/S1470-2045(22)00273-X. Epub 2022 Jun 2.

2022
AO Alessandria
AOU Novara

Tabernero J; Cortellini A; Provenzano S; Gennari A; Fusco V; Generali D; Grisanti S; Mukherjee U; Diamantis N; Libertini M; Tucci M; Prat A; Rimassa L; Aujayeb A; Grosso F; Parisi A; Queirolo P; Mazzoni F; Caliman E; Santoro A; Giusti R; Zambelli A; Cantini L; Martinez-Vila C; Patriarca A; Bruna R; Ruiz-Camps I; Gaidano G; Fox L; et alii...

Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry. in JAMA oncology / JAMA Oncol. 2022 Jan 1;8(1):114-122. doi: 10.1001/jamaoncol.2021.6199.

2022
AOU Novara

Pinato DJ; Patel M; Scotti L; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Bower M; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; et alii...

Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19. in American journal of hematology / Am J Hematol. 2022 Dec;97(12):E470-E473. doi: 10.1002/ajh.26732. Epub 2022 Sep 27.

2022
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Vannucchi AM; Rambaldi A; Curto-Garcia N; Cavalca F; Bellini M; Betti S; Borsani O; de Na??cz AK; Cattaneo D; Bucelli C; Cichocka E; Koschmieder S; Lopez Abadia E; Kusec R; Xicoy Cirici B; Angona A; Navas Elorza B; Sagues Serrano M; Carreno-Tarragona G; Osorio S; Carli G; Hernandez-Boluda JC; Garcia-Gutierrez V; Marin Sanchez A; Magro Mazo E; Griesshammer M; Quiroz Cervantes K; Bolaños Calderón E; Patriarca A; et alii...

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Aug;171:64-74. doi: 10.1016/j.ejca.2022.04.036. Epub 2022 May 23.

2022
AO Alessandria
AOU Novara

Tabernero J; Cortellini A; Gennari A; Prat A; Rimassa L; Aujayeb A; Queirolo P; Delfanti S; Parisi A; Mazzoni F; Santoro A; Filetti M; Berardi R; Martinez-Vila C; Fusco V; Shawe-Taylor M; Patriarca A; Gaidano G; Ruiz-Camps I; Bruna R; Roldán E; Zoratto F; Fox L; Doonga K; Perachino M; Fort-Culillas R; Saoudi-Gonzalez N; Cruz CA; Yu T; et alii...

Precision Medicine in Systemic Mastocytosis. in Medicina (Kaunas, Lithuania) / Medicina (Kaunas). 2021 Oct 20;57(11):1135. doi: 10.3390/medicina57111135.

2021
AOU Novara

Nicolosi M; Patriarca A; Andorno A; Mahmoud AM; Gennari A; Boldorini R; Gaidano G; Crisà E;

A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study. in BMC geriatrics / BMC Geriatr. 2021 May 19;21(1):320. doi: 10.1186/s12877-021-02237-3.

2021
AOU Città della Salute di Torino
AOU Novara

Varughese F; Cappelli M; Burrafato G; Bruna R; Maggiora PM; Biello F; Mahmoud AM; Martini V; Platini F; Deambrogi C; Patriarca A; Nicolosi M; Vachanaram AR; Pisani C; Ferrara E; Catania E; Azzolina D; Barone-Adesi F; Krengli M; Gaidano G; Gennari A;

Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists. in International journal of molecular sciences / Int J Mol Sci. 2021 Mar 3;22(5):2525. doi: 10.3390/ijms22052525.

2021
AOU Novara

Crisà E; Boggione P; Nicolosi M; Mahmoud AM; Al Essa W; Awikeh B; Aspesi A; Andorno A; Boldorini R; Dianzani I; Gaidano G; Patriarca A;

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. in Blood / Blood. 2021 Mar 11;137(10):1365-1376. doi: 10.1182/blood.2020007039.

2021
AOU Città della Salute di Torino
AOU Novara

Jelinek D; Haferlach C; Stilgenbauer S; Hallek M; Oscier D; Fischer K; Anagnostopoulos A; Pott C; Campo E; Niemann C; Francia di Celle P; Gaidano G; Stavroyianni N; Trentin L; Montillo M; Antic D; Foroni L; Espinet B; Costeas P; Panagiotidis P; Alshemmari S; Rossi D; Panovska I; Kater AP; Fais F; Bödör C; Sandaltzopoulos R; Karan-Djurasevic T; Mansouri L; et alii...

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Mar;8(3):e175-e184. doi: 10.1016/S2352-3026(20)30373-2. Epub 2021 Jan 18.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Tognoni G; Finazzi MC; Bellini M; Bucelli C; Lunghi F; Vianelli N; Scaffidi L; Betti S; Guglielmelli P; Loscocco GG; Mora B; Cacciola E; Mannarelli C; Patriarca A; Cascavilla N; Rumi E; Siragusa S; Musolino C; Caramella M; Rapezzi D; Ricco A; Carli G; Palandri F; Pane F; Benevolo G; Bonifacio M; Iurlo A; Ciceri F; Ghirardi A; et alii...

Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia. in Leukemia & lymphoma / Leuk Lymphoma. 2021 Mar;62(3):669-678. doi: 10.1080/10428194.2020.1838509. Epub 2020 Nov 6.

2021
AOU Novara

Efficace F; Iurlo A; Patriarca A; Stagno F; Bee PC; Ector G; Capodanno I; Elena C; Bonifacio M; Blijlevens NMA; Caocci G; Wan C; Abruzzese E; Breccia M; Cottone F; Okumura I; Oerlemans S; Cascavilla N; Albano F; Kota V; Sztankay M; Miggiano MC; Saussele S; Di Renzo N; Sorà F; Castagnetti F; Baccarani M; Vignetti M; Rosti G; et alii...

Long-term follow-up of recovered MPN patients with COVID-19. in Blood cancer journal / Blood Cancer J. 2021 Jun 16;11(6):115. doi: 10.1038/s41408-021-00509-0.

2021
AOU Città della Salute di Torino
AOU Novara

Salmoiraghi S; Rambaldi A; Bellosillo B; Guglielmelli P; Koschmieder S; Borsani O; Betti S; Benajiba L; Garrote M; Cavalca F; Curto-Garcia N; Bellini M; Daffini R; Cuevas B; Cattaneo D; Sobas MA; Xicoy Cirici B; Ruggeri M; Angona A; Hernandez-Boluda JC; Lopez Abadia E; De Stefano V; Bonifacio M; Magro Mazo E; Lunghi F; Garcia-Gutierrez V; Navas Elorza B; Benevolo G; Patriarca A; et alii...

The Biology of Chronic Lymphocytic Leukemia: Diagnostic and Prognostic Implications. in Cancer journal (Sudbury, Mass.) / Cancer J. 2021 Jul-Aug 01;27(4):266-274. doi: 10.1097/PPO.0000000000000534.

2021
AOU Novara

Moia R; Patriarca A; Schipani M; Gaidano G;

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. in Blood cancer journal / Blood Cancer J. 2021 Feb 4;11(2):21. doi: 10.1038/s41408-021-00417-3.

2021
AOU Città della Salute di Torino
AOU Novara

Rambaldi A; Vannucchi AM; Betti S; Harrison C; Curto-Garcia N; Cavalca F; Bellini M; Benajiba L; Bellosillo B; Garrote M; Cattaneo D; Daffini R; Guglielmelli P; Cirici BX; Abadia EL; Carli G; Cuevas B; Hernandez-Boluda JC; Koschmieder S; Angona A; Mazo EM; Lunghi F; Patriarca A; Elorza BN; Serrano MS; Carreno-Tarragona G; Sobas MA; Bonifacio M; Cervantes KSQ; et alii...

Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study. in Haematologica / Haematologica. 2021 Feb 1;106(2):622-625. doi: 10.3324/haematol.2020.250522.

2021
AOU Novara

Hill A; Patriarca A; Zaja F; Jilma B; Mauro FR; Vos JMI; Frederiksen H; Guillet S; Giannotta J; Zaninoni A; Michel M; Fattizzo B; Berentsen S; Barcellini W;

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. in Leukemia / Leukemia. 2021 Feb;35(2):485-493. doi: 10.1038/s41375-020-01107-y. Epub 2021 Jan 7.

2021
AOU Città della Salute di Torino
AOU Novara

Betti S; Harrison C; De Stefano V; Bellini M; Bellosillo B; Benajiba L; Curto-Garcia N; Daffini R; Cavalca F; Cattaneo D; Garrote M; Cirici BX; Guglielmelli P; Abadia EL; Hernandez-Boluda JC; Cuevas B; Ruggeri M; Koschmieder S; Mazo EM; Angona A; Elorza BN; Patriarca A; Carreno-Tarragona G; Sobas MA; Lunghi F; Papadopoulos P; Bonifacio M; Cervantes KSQ; Serrano MS; et alii...

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. in The Lancet. Oncology / Lancet Oncol. 2021 Dec;22(12):1669-1680. doi: 10.1016/S1470-2045(21)00573-8. Epub 2021 Nov 3.

2021
AOU Novara

Tabernero J; Pinato DJ; Bower M; Scotti L; Patel M; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Ottaviani D; Chowdhury A; Merry E; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; et alii...

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia. in Blood / Blood. 2021 Aug 19;138(7):571-583. doi: 10.1182/blood.2021010735.

2021
AOU Città della Salute di Torino
AOU Novara

Vianelli N; Zaja F; De Stefano V; Rodeghiero F; Mazzucconi MG; Cavo M; Sutto E; Carpenedo M; Carli G; Nicolosi D; Baldacci E; Auteri G; Borchiellini A; Giuffrida G; Caocci G; Chiurazzi F; Consoli U; Cantoni S; Oliva EN; Barcellini W; Patriarca A; Rivolti E; Carrai V; Bartoletti D; Ferretti A; Ruggeri M; Lucchini E; Palandri F; Rossi E; et alii...

Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study. in British journal of haematology / Br J Haematol. 2021 Apr;193(2):386-396. doi: 10.1111/bjh.17334. Epub 2021 Feb 22.

2021
AOU Città della Salute di Torino
AOU Novara

Zaja F; Fanin R; Rodeghiero F; Carpenedo M; Giardini I; Gigliotti CL; Boggio E; Dianzani U; Crea E; Vignetti M; Paoloni F; Santoro C; Barcellini W; Celli M; Consoli U; Valeri F; Carli G; Patriarca A; Rossi E; Auteri G; Vianelli N; Volpetti S; Palandri F; Lucchini E;

Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network. in Frontiers in oncology / Front Oncol. 2021 Aug 26;11:739171. doi: 10.3389/fonc.2021.739171. eCollection 2021.

2021
AOU Città della Salute di Torino
AOU Novara

Ciccone G; Baccarani M; Saglio G; Di Raimondo F; Pane F; Rosti G; Musto P; Saccona F; Mulas O; Levato L; Guella A; La Barba G; Pietrantuono G; Miggiano MC; Abruzzese E; Giai V; De Candia MS; Sanpaolo G; Maggi A; Reddiconto G; DiTonno P; Binotto G; Galimberti S; Bocchia M; Sorà F; Rege-Cambrin G; Patriarca A; Fava C; Bergamaschi M; et alii...

Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms. in Frontiers in oncology / Front Oncol. 2021 Oct 26;11:777730. doi: 10.3389/fonc.2021.777730. eCollection 2021.

2021
AOU Novara

Moia R; Cittone MG; Boggione P; Manfredi GF; Favini C; Awikeh B; Pedrinelli AR; Mahmoud AM; Nicolosi M; Bellan M; Sainaghi PP; Pirisi M; Gaidano G; Patriarca A; Rigamonti C;

Atypical Chronic Myeloid Leukemia: Where Are We Now? in International journal of molecular sciences / Int J Mol Sci. 2020 Sep 18;21(18):6862. doi: 10.3390/ijms21186862.

2020
AOU Novara

Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A;

The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index. in Leukemia / Leukemia. 2020 Sep;34(9):2451-2459. doi: 10.1038/s41375-020-0746-8. Epub 2020 Feb 21.

2020
AOU Città della Salute di Torino
AOU Novara

Capodanno I; Frairia C; Fianchi L; Luppi M; Petranovic D; Caers J; Ricco A; Stauder R; Caocci G; Palumbo GA; Platzbecker U; Breccia M; Niscola P; Patriarca A; Cella D; Oswald LB; Cottone F; Efficace F; Follini E; Sarlo C; Fazi P; Vignetti M;

Precision Medicine Management of Chronic Lymphocytic Leukemia. in Cancers / Cancers (Basel). 2020 Mar 10;12(3):642. doi: 10.3390/cancers12030642.

2020
AOU Novara

Moia R; Patriarca A; Schipani M; Ferri V; Favini C; Sagiraju S; Al Essa W; Gaidano G;

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study. in Blood / Blood. 2020 Jan 30;135(5):381-386. doi: 10.1182/blood.2019002614.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Di Veroli A; Barbui T; Vannucchi AM; Rambaldi A; Griesshammer M; Alvarez-Larran A; Marchetti M; Isfort S; Recasens V; McMullin MF; Tieghi A; Carli G; Cacciola R; Benevolo G; Fox ML; Beggiato E; Angona A; Lunghi F; Wille K; Perez-Encinas M; Gomez M; Erez D; Rapezzi D; Elli EM; Palova M; Casetti IC; Stephenson C; Guglielmelli P; Scaffidi L; et alii...

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy. in Leukemia / Leukemia. 2020 Feb;34(2):488-498. doi: 10.1038/s41375-019-0563-0. Epub 2019 Sep 2.

2020
AOU Città della Salute di Torino
AOU Novara

Rosti G; Binotto G; Vignetti M; Bergamaschi M; Fozza C; Cascavilla N; Saussele S; Pregno P; Gozzini A; Patriarca A; Capodanno I; Martino B; Tiribelli M; Crugnola M; Caocci G; Castagnetti F; Abruzzese E; Cottone F; Bonifacio M; Breccia M; Iurlo A; Efficace F; Stagno F;

High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity. in International journal of hematology / Int J Hematol. 2020 Aug;112(2):141-146. doi: 10.1007/s12185-020-02920-y. Epub 2020 Jun 25.

2020
AOU Novara

Caocci G; Vignetti M; Patriarca A; Breccia M; Platzbecker U; Palumbo GA; Stauder R; Cottone F; Petranovic D; Voso MT; Tafuri A; Invernizzi R; Caers J; Luppi M; La Nasa G; Niscola P; Efficace F;

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020.

2020
AOU Città della Salute di Torino
AOU Novara

Cuneo A; Follenzi A; Poeta GD; Bertoni F; Lawless S; Thornton P; Mills K; Donaldson D; Weir P; Motta M; Laurenti L; Tedeschi A; Perbellini O; Coscia M; Marasca R; Rigolin GM; Chiarenza A; Visco C; Rossi FM; Bomben R; Cortelezzi A; Zaja F; Forconi F; Mauro FR; Giudice ID; Peroni D; Kodipad AA; Jabangwe C; Sagiraju S; et alii...